2) Early-stage breast cancer
早期乳腺癌
1.
Herceptin plus adjuvant chemotherahy for the prognosis of patients with human epithelial growth factor receptor 2 positive early-stage breast cancer: a Meta-analysis;
赫赛汀联合辅助化疗对人类表皮生长因子受体2阳性早期乳腺癌患者预后影响的Meta分析
2.
Clinical analysis of breast conserving surgery for early-stage breast cancer in 35 cases;
早期乳腺癌保乳手术35例临床分析
3.
Objective To evaluate the effects of Trastuzumab on the prognosis of HER2 positive patients with early-stage breast cancer by meta-analysis.
目的应用Meta分析的方法探讨曲妥珠单抗对HER2阳性早期乳腺癌患者预后的影响。
3) Advanced breast cancer
晚期乳腺癌
1.
Clinical observation of docetaxel with DDP treating advanced breast cancer;
多烯紫杉醇联合顺铂治疗晚期乳腺癌疗效观察
2.
The comparison of TP and NP regimens in the treatment of advanced breast cancer;
TP与NP方案治疗晚期乳腺癌的临床观察
3.
Clinical observation on docetaxel combined with xeloda in treatment of advanced breast cancer;
希罗达联合艾素治疗晚期乳腺癌的临床观察
4) Early breast cancer
早期乳腺癌
1.
Sentinel-node biopsy and radiotherapy decision for early breast cancer;
早期乳腺癌前哨淋巴结活检与腋窝局部放疗决策
2.
Study of mammography and color Doppler ultrasound in diagnosis of early breast cancer;
钼靶X线摄影和彩色多普勒超声对早期乳腺癌诊断价值的对比分析
3.
Clinical analysis of 26 cases of early breast cancer treated with breast conservation therapy;
早期乳腺癌保乳手术26例临床分析
5) stage Ⅰ breast cancer
Ⅰ期乳腺癌
1.
Objective: To improve the early diagnosis of breast cancer through a study of the mammography and ultrasonography finding of the stage Ⅰ breast cancer.
0 cm的Ⅰ期乳腺癌B超与钼靶的检出率差异无统计学意义(P>0。
6) Ⅲ Stage breast cancer
Ⅲ期乳腺癌
1.
Clinical study on Ⅲ Stage breast cancer patients treated by neoadjuvant chemotherapy;
新辅助化疗对80例Ⅲ期乳腺癌患者5年生存率的回顾性分析
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条